DSM Biomedical
entered a strategic innovation collaboration with China's Peijia Medical in 2025 to develop polymer heart-valve materials using UHMWPE and thermoplastic polyurethane, and maintained an active EuroPCR 2026 presence;…
- Country
- Netherlands
Polymer biomaterials
eu
Coverage
| CN | EU | US | |
|---|---|---|---|
| regenerative-personalized | ✓ | ✓ | ✓ |
Regulatorsfdaemanmpa
Technologies
| Name | Cluster | Risk | |
|---|---|---|---|
| Medical devices with biointerface | regenerative-personalized | Medium | → |
Compiled by BIOECON via the bioecon-brief pipeline.
Compliance
Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.